Market revenue in 2023 | USD 229.5 million |
Market revenue in 2030 | USD 372.7 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 65.53% in 2023. Horizon Databook has segmented the Italy veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
In Italy, several training programs conducted to raise awareness among veterinarians are broadening the scope for market growth over the upcoming decade. Moreover, the increasing pet population in Italy and the growing awareness about the benefits of keeping pets are driving the market.
Numerous untapped opportunities in Italy, economic progress, and significant rise in pet awareness are some other factors accelerating market growth. In addition, the rising government healthcare spending on veterinary care is anticipated to support market growth.
In addition, contributions from government & private entities toward animal health are anticipated to present considerable growth opportunities to the veterinary API manufacturing market. Moreover, high focus on animal disease control for livestock is further boosting the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Italy veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account